PEDIATRICS Vol. 80 No. 2 August 1987, pp. 308
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KOREN, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KOREN, G.

Drug Errors

GIDEON KOREN MD1

1 Division of Clinical Pharmacology, The Hospital For Sick Children, Toronto

In Reply.—

In Canada, pediatric Lanoxin is available, as stated in our article, in a concentration of 0.05 mg/mL (Compendium of Pharmaceuticals and Specialties, ed 21. Ottawa, Canadian Pharmaceutical Association, 1986). This is another source of errors; physicians today moving from country to country should always check the stock solutions of drugs available and not assume that they are the same as at home.